Kliniken Essen-Mitte
Hospital
Location:
Essen,
Germany (DE)
ISNI: 0000000100064176
ROR: https://ror.org/03v958f45
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA (2014)
Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Lu Y, Hein A, et al.
Journal article
Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma (2014)
Loibl S, Volz C, Mau C, Blohmer JU, Costa SD, Eidtmann H, Fasching P, et al.
Journal article
Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40--GeparQuattro) (2014)
Von Minckwitz G, Rezai M, Fasching P, Huober J, Tesch H, Bauerfeind I, Hilfrich J, et al.
Journal article
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk (2014)
Kelemen LE, Terry KL, Goodman MT, Webb PM, Bandera EV, Mcguire V, Rossing MA, et al.
Journal article
Chemotherapy for 70-Year-old women with breast cancer in Germany: A survey by the German breast group (2013)
Barinoff J, Traut A, Bauerschlag DO, Bischoff J, Herr D, Luebbe K, Lueck HJ, et al.
Journal article
Everolimus as treatment for breast cancer patients with bone metastases only: Results of the phase II RADAR study (2013)
Maass N, Harbeck N, Mundhenke C, Lerchenmueller C, Barinoff J, Lueck HJ, Ettl J, et al.
Journal article